BioCardia, Inc. (BCDA) Gross margin 2016–2021
BioCardia, Inc. (BCDA) gross margin by fiscal year — reported gross profit divided by reported revenue.
100.0%FY2021 · since FY2016: -29.5% → 100.0%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2021 | 100.0% | +2.8 pp |
| FY2020 | 97.2% | +47.7 pp |
| FY2019 | 49.6% | +32.3 pp |
| FY2018 | 17.3% | +61.3 pp |
| FY2017 | -44.1% | -14.5 pp |
| FY2016 | -29.5% | — |
Gross margin = reported gross profit ÷ reported revenue for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice
More BCDA financial trends
BCDA RevenueBCDA Net incomeBCDA Net marginBCDA Gross profitBCDA Operating incomeBCDA Operating marginBCDA Operating cash flowBCDA Free cash flowBCDA Capital expendituresBCDA Return on equityBCDA Stock buybacksBCDA Dividends paidBCDA Total assetsBCDA Total liabilitiesBCDA Shareholders’ equityBCDA overview →